News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2022 Todd Neale August 01, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2022 Shelley Wood June 01, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News TCT 2021 Debating ISCHEMIA: Do the Results Apply to CABG, Too? Michael O'Riordan November 10, 2021
News Daily News CTO PCI Ups Survival Amid High Levels of Ischemia in Single-Center Series Yael L. Maxwell July 05, 2021
News Conference News EuroPCR 2021 Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances Caitlin E. Cox May 21, 2021
News Daily News Potent Antiplatelets Pre-CABG for ACS? Meta-analysis Stirs Debate L.A. McKeown February 26, 2021
News Conference News HFSA 2020 Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study L.A. McKeown October 12, 2020
News Conference News ESC 2020 In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD Yael L. Maxwell September 01, 2020
News Conference News EuroPCR 2020 DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions Todd Neale June 30, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Conference News ACC 2020 ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up Shelley Wood March 30, 2020
News Daily News MR Improves in Half of Low-Flow/Low-Gradient AS Patients Undergoing TAVR Michael O'Riordan February 13, 2020
News Opinion Off Script AHA 2019 Off Script: Will ISCHEMIA Answer Our Most Pressing Questions? Ajay Kirtane, MD, SM November 12, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019